Vaccine holds hope of preventing antibiotic resistant skin infections

Vaccine holds hope of preventing antibiotic resistant skin infections
"This is the first published study to demonstrate the effectiveness of a cross-kingdom recombinant vaccine against MRSA skin infections," said Dr. Michael R. Yeaman, lead author of the study. "NDV-3 is unique as it is the first vaccine to demonstrate …
Read more on Medical Xpress

Brilacidin granted QIDP designation to treat skin infections
Biopharmaceutical company, Cellceutix Corporation announced today that the U.S. Food and Drug Administration (FDA) has granted Qualified Infectious Disease Product (QIDP) designation for Brilacidin as a new treatment for Acute Bacterial Skin and Skin …
Read more on Outbreak News Today